Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03956745 · ClinicalTrials.gov registry record
Biomarkers for Circadian Timing in Healthy Adults
A clinical trial, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- 15
- Enrollment target
NCT03956745: Clinical Trial study, sponsored by Brigham and Women's Hospital.
NCT03956745 is a clinical trial that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03956745 was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
Study investigators want to learn more about the underlying biological clock and to see if the timing of that clock can be estimated from a single blood sample.
Primary Outcome
Circadian phase will be predicted by the BodyTime assay during the baseline segment (study day 3) and will be compared to conventional phase assessment methods.
Interventions
- BEHAVIORAL sleep-wake timing
- BEHAVIORAL constant routine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2025-04-30 |
Why NCT03956745 stopped before completion
NCT03956745 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which sleep-wake timing is the first listed.
NCT03956745 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03956745 about?
NCT03956745 is a clinical study titled "Biomarkers for Circadian Timing in Healthy Adults". Study investigators want to learn more about the underlying biological clock and to see if the timing of that clock can be estimated from a single blood sample.
What is the current status of trial NCT03956745?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2021-06-01. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT03956745?
The interventions under investigation include: sleep-wake timing (BEHAVIORAL), constant routine (BEHAVIORAL).
Who is sponsoring clinical trial NCT03956745?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI